Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Therapeutic Plasma Exchange Practices in Immune Thrombocytopenic Purpura Related Hospitalizations: Real World Practices for a Category III Apheresis Indication

Sarah Makhani, BA, Joseph Schwartz, MD MPH, Aaron Tobian, MD PhD, Saurav Chopra, Ljiljana V. Vasovic, MD, Robert Andrew Desimone, MD, Patricia Shi, MD, Shipra Kaicker, MD, Cassandra D Josephson, MD, James B. Bussel, MD, Ruchika Goel, MD MPH

Blood (2018) 132 (Supplement 1): 3757.

https://doi.org/10.1182/blood-2018-99-111425

Published: 2018

Journal Articles

Transfusion Practices and Infections At Four Level III Neonatal Intensive Care Units

Elizabeth M Margolskee, MD, Melissa M. Cushing, MD, Yu-Hui Ferng, MPA, David Friedman, MD, Debra Kessler, RN, Joseph Schwartz, MD, Deborah Sesok-Pizzini, MD, MBA, Beth H Shaz, MD, Yong Zhao, MD, Lisa Saiman, MD, MPH, Eldad A. Hod, MD

Blood (2013) 122 (21): 3657.

https://doi.org/10.1182/blood.V122.21.3657.3657

Published: 2013

Journal Articles

Transfusions of Red Blood Cells Stored for 40–42 Days Induce Circulating Non-Transferrin-Bound Iron (NTBI) In Healthy Adults

Eldad A. Hod, MD, Gary M. Brittenham, MD, Genia B. Billote, Yelena Ginzburg, MD, Shruti Sharma, Boguslaw S. Wojczyk, PhD, Richard O. Francis, MD, PhD, Brie A. Stotler, MD, Anthony Sireci, MD, Hannah L. Stephens, Joseph Schwartz, MD, Gordana Olbina, Mark Westerman, Sujit Sheth, MD, Steven L. Spitalnik, MD

Blood (2010) 116 (21): 662.

https://doi.org/10.1182/blood.V116.21.662.662

Published: 2010

Journal Articles

A Pilot Study of Reduced Toxicity Conditioning (RTC) with Busulfan (Bu), Fludarabine (Flu), and Alemtuzumab Followed by Allogeneic Stem Cell Transplantation (AlloSCT) to Induce Sustained Mixed Donor Chimerism In Patients with Symptomatic Sickle Cell Disease (SCD)

Monica Bhatia, MD, Mark B Geyer, AB, Courtney Baker, RN, MSN, PNP, Erin Morris, RN, BSN, Deirdre Duffy, BS, Diane George, MD, James H Garvin, Jr., MD, PhD, Prakash Satwani, MD, Joseph Schwartz, MD, Sandra Foley, CPNP, Ria Hawks, CPNP, Elana Hamburger-Smilow, CPNP, Lee Ann Baxter-Lowe, PhD, Mitchell S. Cairo, MD

Blood (2010) 116 (21): 3504.

https://doi.org/10.1182/blood.V116.21.3504.3504

Published: 2010

Journal Articles

Dose Escalation of Clofarabine In Combination with Cytarabine and Total Body Irradiation (TBI) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) In Children, Adolescents and Young Adults (CAYA) with Poor-Risk Acute Leukemia

Mark B Geyer, AB, Angela M Ricci, BA, Lauren Harrison, RN, MSN, Deirdre Duffy, BS, Monica Bhatia, MD, James H Garvin, Jr., MD, Diane George, MD, Prakash Satwani, MD, Alexandra C Cheerva, MD, MS, Julie Talano, MD, Fevzi Ozkaynak, MD, Theodore B. Moore, MD, MS, Joseph Schwartz, MD, Lee Ann Baxter-Lowe, PhD, Mitchell S. Cairo, MD

Blood (2010) 116 (21): 36.

https://doi.org/10.1182/blood.V116.21.36.36

Published: 2010

Journal Articles

Reduced Toxicity Conditioning (RTC) Compared to Myeloablative Conditioning (MAC) Prior to Unrelated Cord Blood Transplantation (UCBT) in Pediatric Recipients Was Associated with Similar but Also Delayed Time to Immune Reconstitution and a Concomitant Significant Decrease in Grade II-IV Agvhd.

Jason Freedman, M.D., Diane George, MD, Judith Jacobson, DrPH, MBA, Mark Geyer, AB, Carmella van de Ven, MA, Nathifa Fearon, RN, MSN, Claire Fanelli, RN, BSN, Bradford Tallamy, BA, Prakash Satwani, MD, Monica Bhatia, MD, James H. Garvin, Jr., MD, M. Brigid Bradley, MD, Tracey Schonfeld, RN, BSN, Lauren Harrison, RN, Erin Morris, RN, Joseph Schwartz, MD, Lee Ann Baxter-Lowe, PhD, Mitchell S. Cairo, MD

Blood (2009) 114 (22): 2304.

https://doi.org/10.1182/blood.V114.22.2304.2304

Published: 2009

Journal Articles

Enhanced T Cell Function in Patients with Hematological Malignanicies Undergoing Mobilization for Autologous Stem Cell Transplantation.

Adriana I. Colovai, PhD, Joseph Schwartz, MD, Ronit Slotky, PhD, Zhouru Liu, PhD, Jianshe Fan, PhD, Nida Kabbaj, MS, David G. Savage, MD, Ajai Chari, MD, Steven L. Spitalnik, MD, Nicole Suciu-Foca, PhD

Blood (2007) 110 (11): 3288.

https://doi.org/10.1182/blood.V110.11.3288.3288

Published: 2007

NARROW

Therapeutic Plasma Exchange Practices in Immune Thrombocytopenic Purpura Related Hospitalizations: Real World Practices for a Category III Apheresis Indication

Transfusion Practices and Infections At Four Level III Neonatal Intensive Care Units

Transfusions of Red Blood Cells Stored for 40–42 Days Induce Circulating Non-Transferrin-Bound Iron (NTBI) In Healthy Adults

A Pilot Study of Reduced Toxicity Conditioning (RTC) with Busulfan (Bu), Fludarabine (Flu), and Alemtuzumab Followed by Allogeneic Stem Cell Transplantation (AlloSCT) to Induce Sustained Mixed Donor Chimerism In Patients with Symptomatic Sickle Cell Disease (SCD)

Dose Escalation of Clofarabine In Combination with Cytarabine and Total Body Irradiation (TBI) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) In Children, Adolescents and Young Adults (CAYA) with Poor-Risk Acute Leukemia

Reduced Toxicity Conditioning (RTC) Compared to Myeloablative Conditioning (MAC) Prior to Unrelated Cord Blood Transplantation (UCBT) in Pediatric Recipients Was Associated with Similar but Also Delayed Time to Immune Reconstitution and a Concomitant Significant Decrease in Grade II-IV Agvhd.

Enhanced T Cell Function in Patients with Hematological Malignanicies Undergoing Mobilization for Autologous Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Therapeutic Plasma Exchange Practices in Immune Thrombocytopenic Purpura Related Hospitalizations: Real World Practices for a Category III Apheresis Indication

Transfusion Practices and Infections At Four Level III Neonatal Intensive Care Units

Transfusions of Red Blood Cells Stored for 40–42 Days Induce Circulating Non-Transferrin-Bound Iron (NTBI) In Healthy Adults

A Pilot Study of Reduced Toxicity Conditioning (RTC) with Busulfan (Bu), Fludarabine (Flu), and Alemtuzumab Followed by Allogeneic Stem Cell Transplantation (AlloSCT) to Induce Sustained Mixed Donor Chimerism In Patients with Symptomatic Sickle Cell Disease (SCD)

Dose Escalation of Clofarabine In Combination with Cytarabine and Total Body Irradiation (TBI) Followed by Allogeneic Stem Cell Transplantation (AlloSCT) In Children, Adolescents and Young Adults (CAYA) with Poor-Risk Acute Leukemia

Reduced Toxicity Conditioning (RTC) Compared to Myeloablative Conditioning (MAC) Prior to Unrelated Cord Blood Transplantation (UCBT) in Pediatric Recipients Was Associated with Similar but Also Delayed Time to Immune Reconstitution and a Concomitant Significant Decrease in Grade II-IV Agvhd.

Enhanced T Cell Function in Patients with Hematological Malignanicies Undergoing Mobilization for Autologous Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only